Together against prostate cancer
13 August 2024New, repurposed and combined treatments could soon transform prostate cancer outcomes, with DNA repair research informing promising clinical trials at Cambridge.
Protein discovery may explain why some patients develop resistance to new class of anti-cancer drugs
25 July 2018A team of researchers at the University of Cambridge has identified a protein complex that might explain why some cancer patients treated with the revolutionary new anti-cancer drugs known as PARP inhibitors develop resistance to their medication.
